BCR-ABL1-positive CML and BCR-ABL1-negative chronic myeloproliferative disorders: some common and contrasting features

Leukemia. 2008 Nov;22(11):1975-89. doi: 10.1038/leu.2008.231.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Chronic Disease
  • Clinical Trials as Topic
  • Fusion Proteins, bcr-abl / genetics*
  • Genomic Instability
  • Humans
  • Janus Kinase 2 / genetics
  • Janus Kinase 2 / metabolism
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / pathology
  • Myeloproliferative Disorders / therapy

Substances

  • Fusion Proteins, bcr-abl
  • JAK2 protein, human
  • Janus Kinase 2